Company Filing History:
Years Active: 2023
Title: The Innovations of Wenfang Zhao
Introduction
Wenfang Zhao is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on dabigatran etexilate. His research focuses on improving the bioavailability and stability of pharmaceutical compositions.
Latest Patents
Wenfang Zhao holds a patent for a pharmaceutical composition containing dabigatran etexilate and a preparation method thereof. This composition includes a pharmaceutically active ingredient, dabigatran etexilate and/or dabigatran etexilate mesylate, along with an amphiphilic polymer of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer. The mass ratio of these components ranges from 1:0.23 to 1:3. This innovative formulation not only enhances the bioavailability of the active ingredient but also reduces absorption variability, providing a more stable concentration of dabigatran in plasma and minimizing adverse side effects.
Career Highlights
Wenfang Zhao is currently associated with Shanghai WD Pharmaceutical Co., Ltd. His work at this company has been instrumental in advancing pharmaceutical formulations and improving patient outcomes through innovative drug delivery systems.
Collaborations
Wenfang Zhao has collaborated with notable colleagues such as Liang Chang Dong and Shizhong Zhang. These partnerships have contributed to the development of his patented pharmaceutical compositions.
Conclusion
Wenfang Zhao's contributions to the pharmaceutical industry through his innovative patent demonstrate his commitment to enhancing drug efficacy and safety. His work continues to impact the field positively, paving the way for future advancements in pharmaceutical compositions.